Feline spironolactone-related heart conditions can lead to decreased cardiac function, making proper management and treatment essential. It is important to choose effective products and care strategies under the guidance of a veterinarian.





| Item | BEST 1 Capsule | BEST 2 Liquid | BEST 3 Combination Product |
|---|---|---|---|
| Ingredient Purity | High | Medium | Medium |
| Ease of Administration | Very high | High | High |
| Possibility of Side Effects | Low when kidneys are normal; monitoring for hyperkalemia needed | Low when kidneys are normal; monitoring for hyperkalemia needed | Low when kidneys are normal; monitoring for hyperkalemia needed |
| Additional Ingredients | None | None | Glucosamine, omega-3, vitamin E (cardiac effect unconfirmed by evidence) |
| Veterinary Prescription Required | True | True | True |
Spironolactone is a prescription-only drug requiring a veterinarian's prescription, and its use is restricted in cats with reduced kidney function or hyperkalemia[E1][E13]. Before administration, a check-up and kidney and potassium tests are essential.
Precautions and Contraindications
Spironolactone use is restricted in cats with impaired kidney function or hyperkalemia. The risk of hyperkalemia increases when it is used in combination with other potassium-sparing diuretics, ACE inhibitors, ARBs, or NSAIDs, so avoid concurrent administration. If your cat shows gastrointestinal symptoms such as loss of appetite, nausea, vomiting, or dehydration while taking the medication, seek veterinary care immediately. Skin ulcers have also been reported in some cats, including Maine Coons. Only administer medications prescribed by your veterinarian.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Payne JR, Borgeat K, Brodbelt DC, Connolly DJ, Luis Fuentes V: Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy, J Vet Cardiol 17(Suppl 1):S318-S328, 2015.
[2] Jaisser F, Farman N: Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology, Pharmacol Rev 68:49-75, 2016.
[3] Plumb's Veterinary Drug Handbook, 10th Ed, 2023. Spironolactone: Use in feline cardiovascular disease.